Abstract
The purpose of this study was to characterize the antiproliferative activity of a recombinant interferon-α (IFN-α) against a newly established human adenocarcinoma cell line (DMS-4C) and to determine whether IFN-α entrapped in multilamellar liposomes had superior antitumor effects compared with free IFN-α. Treatment of DMS-4C cells with 100 U/ml of free IFN-α resulted in 34% cytostasis. IFN-α encapsulated in phosphatidylcholine/phosphatidylserine multilamellar vesicles produced growth inhibition of 67%, which was significantly greater than that produced by free IFN-α or by control liposomes containing only medium combined with free IFN-α. Moreover, kinetic analysis revealed that to produce significant cytolysis, free IFN-α had to be incubated with target cells for at least 24 h, whereas IFN-α encapsulated into liposomes required only 30 min of exposure.
Original language | English (US) |
---|---|
Pages (from-to) | 355-360 |
Number of pages | 6 |
Journal | Journal of Biological Response Modifiers |
Volume | 9 |
Issue number | 4 |
State | Published - Aug 1990 |
Keywords
- Antiproliferative activity
- Interferon
- Liposomes
- Lung cancer
ASJC Scopus subject areas
- Immunology
- Pharmacology
- Cancer Research